IP Verse

Janssen Pharmaceutica Nv opposition analysis

COMPANY ANALYSIS

Latest patents of Janssen Pharmaceutica Nv opposed by its competitors

Patent:
EP3609497
Grant Date:
Oct 12, 2022
Title:
Combination Therapy For Prostate Cancer
Oppositions:
3
Patent:
EP2234617
Grant Date:
Mar 31, 2021
Title:
Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters
Oppositions:
20
Patent:
EP3311374
Grant Date:
Jul 22, 2020
Title:
Devices And Methods For Drug Administration And Mixing, And Training Of Proper Techniques Therefor
Oppositions:
1
Patent:
EP3280416
Grant Date:
Apr 22, 2020
Title:
Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters
Oppositions:
8
Patent:
EP3087098
Grant Date:
Apr 8, 2020
Title:
Anti-Vista Antibodies And Fragments
Oppositions:
2
Patent:
EP2968221
Grant Date:
Jun 19, 2019
Title:
Pharmaceutical Composition Of S-Ketamine Hydrochloride
Oppositions:
2
Patent:
EP2451482
Grant Date:
May 1, 2019
Title:
Combination Therapy For The Treatment Of Diabetes
Oppositions:
2
Patent:
EP2519231
Grant Date:
Mar 15, 2017
Title:
Treatment Of Disease With Proteasome Inhibitors Background Of The Invention
Oppositions:
1

Competitors of Janssen Pharmaceutica Nv

ACCORD HEALTHCARE LTD

DF-MP DORRIES FRANK-MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB

GENERICS [UK] LIMITED

Want to track Janssen Pharmaceutica Nv?

Feel free to send us a message here and we will get back to you